Stay updated with breaking news from Adxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research note issued to investors on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded Ayala Pharmaceuticals from a neutral rating to a buy rating in a research report on Tuesday, May […]
Investment analysts at StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a report issued on Thursday. The brokerage set a “sell” rating on the stock. Ayala Pharmaceuticals Price Performance Ayala Pharmaceuticals Company Profile (Get Rating) Ayala Pharmaceuticals, Inc, a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule […]
Stock analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research note issued on Sunday. The firm set a “sell” rating on the stock. Ayala Pharmaceuticals Stock Performance About Ayala Pharmaceuticals (Get Rating) Ayala Pharmaceuticals, Inc, a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule […]
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (OTCMKTS:ADXS – Get Rating) in a research note issued to investors on Wednesday. The firm issued a sell rating on the biotechnology company’s stock. Separately, LADENBURG THALM/SH SH upgraded Ayala Pharmaceuticals from a neutral rating to a buy rating in a research report on Tuesday, May 30th. […]
Ayala Pharmaceuticals, Inc. (OTCMKTS:ADXS – Get Rating)’s share price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.25 and traded as high as $1.30. Ayala Pharmaceuticals shares last traded at $1.27, with a volume of 5,504 shares changing hands. Analyst […]